Archive for March 3rd, 2008
Alemtuzumab
U.S. BRAND NAMES — Campath®PHARMACOLOGIC CATEGORY Antineoplastic Agent, Monoclonal AntibodyDOSING: ADULTS B-CLL: I.V. infusion, SubQ (unlabeled route): Initial: 3 mg/day beginning on day 1; when tolerated, increase to 10 mg/day; when tolerated, increase to maintenance dose of 30 mg/day 3 times/week on alternate days for up to 12 weeks Maximum dose/day: 30 mg; [...]
Read Full Post | Make a Comment ( None so far )Alefacept
U.S. BRAND NAMES — Amevive®PHARMACOLOGIC CATEGORY Monoclonal AntibodyDOSING: ADULTS — Psoriasis (moderate-to-severe chronic plaque psoriasis):I.M.: 15 mg once weekly; usual duration of treatment: 12 weeksSecond course: A second course of treatment may be initiated at least 12 weeks after completion of the initial course of treatment, provided CD4+ T-lymphocyte counts are within the normal range.Note: [...]
Read Full Post | Make a Comment ( None so far )Aldesleukin
U.S. BRAND NAMES — Proleukin®PHARMACOLOGIC CATEGORY Biological Response ModulatorDOSING: ADULTS — Refer to individual protocols.Renal cell carcinoma: I.V.: 600,000 int. units/kg every 8 hours for a maximum of 14 doses; repeat after 9 days for a total of 28 doses per course. Retreat if needed 7 weeks after previous course.Melanoma: I.V.: [...]
Read Full Post | Make a Comment ( None so far )« Previous Entries
